Cardiology (all articles)
Cohort Study | Purpose in life (Ikigai) and employment status in relation to cardiovascular mortality.
14 Oct, 2022 | 14:06h | UTC
Review | Heart failure after right ventricular myocardial infarction.
14 Oct, 2022 | 14:05h | UTCHeart Failure After Right Ventricular Myocardial Infarction – Current Heart Failure Reports
2022 ACC Guidance on the evaluation and disposition of acute chest pain in the ED.
13 Oct, 2022 | 13:55h | UTCCommentary: Guideline Guidance: Practical Tips for Finding, Triaging Chest Pain in the ED – TCTMD
Related:
2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain.
Navigating a Complicated World | Commentary of the new AHA/ACC Chest Pain Guidelines.
Commentary from one of the authors on Twitter (thread – click for more)
Now out in @JACCJournals, pleased to share our @ACCinTouch Expert Consensus Decision Pathway on the Evaluation of Acute Chest Pain in the ED led by Chair @Mikekontos1 and Vice-Chair Dr. James De Lemos.
Link: https://t.co/qFg2IGc0io
Thread?
— Cian McCarthy (@CianPMcCarthy) October 12, 2022
RCT | Allopurinol does not improve outcomes in patients with ischemic heart disease without previous gout.
13 Oct, 2022 | 13:53h | UTCInvited Commentary: Xanthine oxidase inhibition for cardiovascular disease prevention – The Lancet
Commentary on Twitter
Despite favorable effects on surrogate endpoints in smaller trials, in an RCT trial of 5,721 pts with CAD, allopurinol did not significantly improve cardiovascular prognosis compared to placebo https://t.co/ITW4HAwI2K @TheLancet pic.twitter.com/EggHM8flle
— Pradeep Natarajan (@pnatarajanmd) October 7, 2022
Under a Creative Commons Attribution (CC BY 4.0) License
Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the US.
13 Oct, 2022 | 13:51h | UTC
Commentary on Twitter (thread – click for more)
Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines
1. There is a notable increased incidence, age 12-39, males, with each dose (Table)https://t.co/XXQbyeLiSP pic.twitter.com/wLTZT3fppy— Eric Topol (@EricTopol) October 12, 2022
Commentary on Twitter
Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines
1. There is a notable increased incidence, age 12-39, males, with each dose (Table)https://t.co/XXQbyeLiSP pic.twitter.com/wLTZT3fppy— Eric Topol (@EricTopol) October 12, 2022
Case series and systematic review | Life-threatening cardiac arrhythmia and sudden death during electronic gaming.
13 Oct, 2022 | 13:49h | UTCEditorial: Ventricular arrhythmias during electronic gaming: Sudden victory and sudden death – Heart Rhythm
News Release: Electronic gaming can trigger potentially lethal heart rhythm problems in susceptible children – Elsevier
Expert Consensus | Screening, diagnosis and follow-up of Brugada syndrome in children.
13 Oct, 2022 | 13:47h | UTC
Cohort Study | Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention.
13 Oct, 2022 | 13:42h | UTC
Commentary on Twitter
Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary interventionhttps://t.co/eRrLLruy7E pic.twitter.com/FPOe9KM5BL
— Open Heart (@Open_HeartBMJ) October 12, 2022
Cohort Study | A collaborative home-based palliative care intervention for patients with heart failure reduced the risk of dying in the hospital.
13 Oct, 2022 | 13:37h | UTCCommentary: Home-Based Palliative Care for Heart Failure May Cut Risk for Dying in Hospital – HealthDay
Commentary on Twitter
Patients who received home-based, interdisciplinary palliative care were more likely to die at home than in hospital, compared to those who received usual care: https://t.co/JsLvANgcPK@kieranlquinn @PTanuseputro @sarina_isenberg #PalliativeCare #HeartFailure pic.twitter.com/6rOPtYQw2h
— CMAJ (@CMAJ) September 26, 2022
Review | Permissive cardiotoxicity: the clinical crucible of cardio-oncology.
13 Oct, 2022 | 13:35h | UTCPermissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology – JACC: CardioOncology
Cohort Study | Cardiovascular morbidity in monoclonal gammopathy of undetermined significance.
13 Oct, 2022 | 13:34h | UTC
RCT | No difference in cardiovascular outcomes with evening vs. morning dosing of usual antihypertensives.
12 Oct, 2022 | 14:01h | UTCRelated Consensus Statement: Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension – Journal of Hypertension
Related study (conflicting results): Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial
Perioperative cardiovascular assessment guideline: focus on managing patients with percutaneous coronary intervention.
12 Oct, 2022 | 13:56h | UTC
Guideline | Evaluation and management of venous thromboembolism.
12 Oct, 2022 | 13:55h | UTCJoint Guideline on Venous Thromboembolism – 2022 – Arquivos Brasileiros de Cardiologia
Guideline | Evaluation and management of myocarditis.
12 Oct, 2022 | 13:56h | UTC
Perspective | Hydrochlorothiazide vs. chlorthalidone – what is the difference?
11 Oct, 2022 | 13:40h | UTCHydrochlorothiazide Versus Chlorthalidone–What is the Difference? – Circulation (free for a limited period)
Related:
Meta-analysis: Chlorthalidone vs. hydrochlorothiazide
Commentary on Twitter
There are big differences among diuretics even within the same class. So let us rethink the class effect. https://t.co/ruE4IYeFf2. Here I discuss what we know about HCTZ vs CTD. pic.twitter.com/cyljdi04v9
— Rajiv Agarwal MD, MS (@AgarwalRajivMD) October 8, 2022
AHA Scientific Statement | Leveraging implementation science for cardiovascular health equity.
11 Oct, 2022 | 13:36h | UTC
Consensus recommendations for screening and managing childhood cancer survivors at risk for cardiomyopathy.
11 Oct, 2022 | 13:35h | UTCRelated:
Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia
Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications.
11 Oct, 2022 | 13:33h | UTC
Review | Therapeutic management of anomalous coronary arteries originating from the opposite sinus of Valsalva.
11 Oct, 2022 | 13:32h | UTC
Commentary from the author on Twitter
Hot off the press?: happy to share our review in @JAHA_AHA highlighting the management of #ACAOS #AAOCA considering pathophysiology and hemodynamics. @biglermarius @MassimoPadalin3 @MatthiasSiepe @RaberLorenz https://t.co/25hRZlj9wR pic.twitter.com/3F1Oqucq7G
— Christoph Gräni (@chrisgraeni) October 8, 2022
Under a Creative Commons Attribution‐NonCommercial License
Calculator | Estimating individual lifetime risk of cardiovascular events in adults with type 2 diabetes.
11 Oct, 2022 | 13:29h | UTCSee also: DIAL Model Calculator
RCT | Riociguat improved hemodynamics but increased dropouts in pulmonary hypertension and HFpEF.
11 Oct, 2022 | 13:26h | UTC
Commentary on Twitter
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: results of randomized, double-blind, placebo-controlled, multicentre trial out.https://t.co/FYmorikQR5#HFpEF #HF #cardiotwitter @ESC_Journals @escardio pic.twitter.com/4sSeYt7Adq
— EHJ Editor-in-Chief (@ehj_ed) October 7, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A | Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy.
11 Oct, 2022 | 13:24h | UTC
Review | Effective hemodynamic monitoring.
7 Oct, 2022 | 14:21h | UTCEffective hemodynamic monitoring – Critical Care
Cohort Study | Albuminuria as a marker of systemic congestion in patients with heart failure.
7 Oct, 2022 | 14:19h | UTC